These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1009 related articles for article (PubMed ID: 24071851)

  • 1. Emerging landscape of oncogenic signatures across human cancers.
    Ciriello G; Miller ML; Aksoy BA; Senbabaoglu Y; Schultz N; Sander C
    Nat Genet; 2013 Oct; 45(10):1127-33. PubMed ID: 24071851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
    PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
    Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
    Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Kamalakaran S; Levine DA; Dimitrova N; Lucito R
    Methods Mol Biol; 2013; 1049():35-51. PubMed ID: 23913207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer patterns of somatic copy number alteration.
    Zack TI; Schumacher SE; Carter SL; Cherniack AD; Saksena G; Tabak B; Lawrence MS; Zhsng CZ; Wala J; Mermel CH; Sougnez C; Gabriel SB; Hernandez B; Shen H; Laird PW; Getz G; Meyerson M; Beroukhim R
    Nat Genet; 2013 Oct; 45(10):1134-40. PubMed ID: 24071852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pan-cancer analysis of gain-of-functional mutations to identify the common oncogenic signatures in multiple cancers.
    Wee Y; Liu Y; Bhyan SB; Lu J; Zhao M
    Gene; 2019 May; 697():57-66. PubMed ID: 30796966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.
    Roszik J; Wu CJ; Siroy AE; Lazar AJ; Davies MA; Woodman SE; Kwong LN
    Sci Rep; 2016 Jan; 6():19649. PubMed ID: 26787600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
    Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
    Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer.
    Soumerai TE; Donoghue MTA; Bandlamudi C; Srinivasan P; Chang MT; Zamarin D; Cadoo KA; Grisham RN; O'Cearbhaill RE; Tew WP; Konner JA; Hensley ML; Makker V; Sabbatini P; Spriggs DR; Troso-Sandoval TA; Charen AS; Friedman C; Gorsky M; Schweber SJ; Middha S; Murali R; Chiang S; Park KJ; Soslow RA; Ladanyi M; Li BT; Mueller J; Weigelt B; Zehir A; Berger MF; Abu-Rustum NR; Aghajanian C; DeLair DF; Solit DB; Taylor BS; Hyman DM
    Clin Cancer Res; 2018 Dec; 24(23):5939-5947. PubMed ID: 30068706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers.
    Cohen AL; Piccolo SR; Cheng L; Soldi R; Han B; Johnson WE; Bild AH
    BMC Med Genomics; 2013 Sep; 6():35. PubMed ID: 24079712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
    Bild AH; Yao G; Chang JT; Wang Q; Potti A; Chasse D; Joshi MB; Harpole D; Lancaster JM; Berchuck A; Olson JA; Marks JR; Dressman HK; West M; Nevins JR
    Nature; 2006 Jan; 439(7074):353-7. PubMed ID: 16273092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrative analysis of the age-associated multi-omic landscape across cancers.
    Chatsirisupachai K; Lesluyes T; Paraoan L; Van Loo P; de Magalhães JP
    Nat Commun; 2021 Apr; 12(1):2345. PubMed ID: 33879792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer analysis of m
    He Y; Yu X; Zhang M; Guo W
    World J Surg Oncol; 2021 Jul; 19(1):224. PubMed ID: 34325709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan-cancer analysis.
    Liu H; Zhang B; Sun Z
    Cancer Commun (Lond); 2020 Jan; 40(1):43-59. PubMed ID: 32067422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases.
    Chen F; Zhang Y; Gibbons DL; Deneen B; Kwiatkowski DJ; Ittmann M; Creighton CJ
    Clin Cancer Res; 2018 May; 24(9):2182-2193. PubMed ID: 29440175
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.
    Choi W; Ochoa A; McConkey DJ; Aine M; Höglund M; Kim WY; Real FX; Kiltie AE; Milsom I; Dyrskjøt L; Lerner SP
    Eur Urol; 2017 Sep; 72(3):354-365. PubMed ID: 28365159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies.
    Naderi A
    Chromosome Res; 2020 Dec; 28(3-4):307-330. PubMed ID: 32816122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative epigenetic and genetic pan-cancer somatic alteration portraits.
    Salas LA; Johnson KC; Koestler DC; O'Sullivan DE; Christensen BC
    Epigenetics; 2017 Jul; 12(7):561-574. PubMed ID: 28426276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.